Department of Surgery, Yonsei University College of Medicine, #50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Department of Surgery, Vicente Sotto MemorialMedical Center, B. Rodriguez street, Cebu City, 6000, Philippines.
Langenbecks Arch Surg. 2019 Nov;404(7):895-908. doi: 10.1007/s00423-019-01833-7. Epub 2019 Dec 3.
A laparoscopic approach is increasingly being utilized in simultaneous colorectal and liver resection (SCLR) for colorectal cancer with liver metastasis. However, this approach is technically challenging and hence has not been widely adopted. Robotic surgical systems could potentially overcome this problem. We aim to describe the feasibility and outcomes of robotic SCLR for colorectal carcinoma with liver metastasis.
The medical records of 12 patients who underwent robotic SCLR for colorectal cancer with liver metastasis between January 2008 and September 2018 were reviewed retrospectively.
The mean age was 59 years (range, 37-77 years). The liver resections were comprised of two right hepatectomies, one left hepatectomy, one left lateral sectionectomy, one segmentectomy of S3 and wedge resection (segment 7), one caudate lobectomy, one associated liver partition and portal vein ligation for staged hepatectomy, and five wedge resections involving segments 4, 5, 6, 7, or 8. The colorectal procedures involved seven low-anterior resections, two anterior resections, two right hemicolectomies, and one left hemicolectomy. The mean operative time was 449 min (range, 135-682 min) with a mean estimated blood loss of 274.3 mL (range, 40-780 mL). The mean length of hospital stay was 12 days (range, 5-28 days). No patients required conversion to laparotomy. Liver resection-related complications were two liver abscesses (Clavien-Dindo classification, one grade II and one grade III) and one case of ascites (grade I), whereas colorectal resection-related complications included one anastomosis leak (grade III) and one superficial wound infection (grade II). There were no deaths reported within 30 days of the procedure. With a mean follow-up duration of 31.5 ± 26.1 months, the overall survival and disease-free survival values were 75.2 and 47.1 months, respectively.
Robotic SCLR for colorectal neoplasm with liver metastasis can be performed safely even in cases requiring major liver resections, especially in a specialized center with a well-trained team.
腹腔镜技术在结直肠癌伴肝转移的同时结直肠和肝切除术(SCLR)中应用日益增多。然而,这种方法在技术上具有挑战性,因此尚未广泛采用。机器人手术系统可能会克服这个问题。我们旨在描述机器人辅助 SCLR 治疗结直肠癌伴肝转移的可行性和结果。
回顾性分析 2008 年 1 月至 2018 年 9 月期间 12 例行机器人 SCLR 治疗结直肠癌伴肝转移患者的病历。
患者的平均年龄为 59 岁(范围,37-77 岁)。肝切除术包括 2 例右半肝切除术、1 例左半肝切除术、1 例左外侧叶切除术、1 例 S3 段切除术和楔形切除术(第 7 段)、1 例尾状叶切除术、1 例联合肝段分区和门静脉结扎分期肝切除术和 5 例楔形切除术,涉及第 4、5、6、7 或 8 段。结直肠手术包括 7 例低位前切除术、2 例前切除术、2 例右半结肠切除术和 1 例左半结肠切除术。平均手术时间为 449 分钟(范围,135-682 分钟),平均估计失血量为 274.3 毫升(范围,40-780 毫升)。平均住院时间为 12 天(范围,5-28 天)。无患者需要转为开腹手术。肝切除术后并发症包括 2 例肝脓肿(Clavien-Dindo 分级,1 级和 1 级)和 1 例腹水(1 级),而结直肠切除术后并发症包括 1 例吻合口漏(3 级)和 1 例浅表伤口感染(2 级)。术后 30 天内无死亡报告。平均随访 31.5±26.1 个月,总生存率和无病生存率分别为 75.2 和 47.1 个月。
机器人辅助 SCLR 治疗结直肠癌伴肝转移即使需要进行主要的肝切除术也可安全进行,特别是在具有专业团队和丰富经验的中心。